4.6 Review

Functions of RANKL/RANK/OPG in bone modeling and remodeling

期刊

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
卷 473, 期 2, 页码 139-146

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2008.03.018

关键词

bone resorption; osteoclasts; RANKL; RANK; OPG

资金

  1. NIAMS NIH HHS [R01 AR043510-13, R01 AR043510, R21 AR049305, R21 AR049305-02] Funding Source: Medline

向作者/读者索取更多资源

The discovery of the RANKL/RANK/OPG system in the mid 1990s for the regulation of bone resorption has led to major advances in our understanding of how bone modeling and remodeling are regulated. It had been known for many years before this discovery that osteoblastic Stromal cells regulated osteoclast formation, but it had not been anticipated that they would do this through expression of members of the TNF superfamily: receptor activator of NF-kappa B ligand (RANKL) and osteoprotegerin (OPG), or that these cytokines and signaling through receptor activator of NF-kappa B (RANK) would have extensive functions beyond regulation of bone remodeling. RANKL/RANK signaling regulates osteoclast formation, activation and survival in normal bone modeling and remodeling and in a variety of pathologic conditions characterized by increased bone turnover. OPG Protects bone from excessive resorption by binding to RANKL and preventing it from binding to RANK. Thus, the relative concentration of RANKL and OPG in bone is a major determinant of bone mass and strength. Here, we review our current understanding of the role of the RANKL/RANK/OPG system in bone modeling and remodeling. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据